Hair Loss and Effectiveness
Yes, 66.3% of patients in the multi-center clinical study kept at least 50% of their hair. Typically, patients will start to see shedding (overall thinning ...
Tue, 17 Oct, 2017 at 12:55 PM
Clinical success The DigniCap Clinical trial demonstrated a success rate of about 66% for patients on Taxane-based regimens. (Success is defined as losing...
Mon, 19 Apr, 2021 at 12:18 PM
Scalp cooling works by constricting the blood vessels, limiting the amount of chemo being introduced to the hair follicle, thus reducing the amount of hair ...
Mon, 19 Apr, 2021 at 12:17 PM
No. DigniCap prevents hair loss on the scalp area, where cooling is applied and therefore does not prevent eyebrow or eyelashes from thinning.
Tue, 17 Oct, 2017 at 11:47 AM
Cooling of the scalp is a proven approach to reduce chemotherapy-induced hair loss that has been used successfully by thousands of patients worldwide with ...
Tue, 17 Oct, 2017 at 1:11 PM
Scalp cooling has been evaluated mainly with regimens including anthracyclines (such as doxorubicin and epirubicin) and taxanes (such as paclitaxel and docet...
Tue, 17 Oct, 2017 at 1:18 PM
No. Scalp metastases is the development of secondary malignancy at a site away from the primary cancer growth. Scalp cooling does not increase this risk, ...
Tue, 17 Oct, 2017 at 1:26 PM